Cytocare 502 (10 vials x 5 ml)

Strictly contraindicated. No clinical safety data exists for peptide and vitamin-heavy injectables during pregnancy or breastfeeding. We prioritize maternal health and recommend deferring all elective aesthetic procedures until after the nursing period has concluded.

The formulation contains 2 mg of non-crosslinked Hyaluronic Acid per 5 ml vial and the CT50 complex (including Vitamins B1, B2, B3, B4, B5, B6, B7, B8, B9, B12, and 21 Amino Acids).

Common reactions include temporary redness, mild papules, and occasional purple bruising at the injection points. These effects are generally minimal and resolve within 24 hours. Patients should strictly follow our expert aftercare guide to ensure a smooth recovery. While risks are low, always have Liporase (Hyaluronidase) available in the clinic as a standard precaution for any multi-product session.

The standard protocol involves an initial phase of 3 sessions, spaced 3 weeks apart, followed by maintenance every 3 to 4 months. One 5 ml vial is usually sufficient to treat the entire face and upper neck area. Practitioners should evaluate if targeted 0.5 ml micro-dosing is appropriate for early-stage periorbital fine lines during a global revitalization session.

Cytocare 502 works by providing the specific substrates needed for fibroblast activity and cellular protection. The non-crosslinked HA creates a hydration reservoir, while the CT50 complex (vitamins and amino acids) neutralizes free radicals and supports the synthesis of collagen and elastin. This biological maintenance approach prevents the "thinning" of the dermis that occurs with early chronological aging.

Avoid alcohol for 24h before and 48h after the procedure. Alcohol consumption acts as a vasodilator and dehydrator, which can exacerbate post-injection swelling and increase the risk of visible bruising at the numerous mesotherapy entry points.